(Q36084344)

English

Neoadjuvant chemotherapy with gemcitabine for pancreatic cancer increases in situ expression of the apoptosis marker M30 and stem cell marker CD44.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Neoadjuvant chemotherapy with gemcitabine for pancreatic cancer increases in situ expression of the apoptosis marker M30 and stem cell marker CD44. (English)

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

pancreatic cancer

1 reference

based on heuristic

inferred from title

author name string

Hidehiro Tajima

1

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Tetsuo Ohta

2

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Hirohisa Kitagawa

3

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Koichi Okamoto

4

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Seisho Sakai

5

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Jun Kinoshita

6

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Isamu Makino

7

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Hiroyuki Furukawa

8

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Hironori Hayashi

9

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Keishi Nakamura

10

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Katsunobu Oyama

11

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Masafumi Inokuchi

12

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Hisatoshi Nakagawara

13

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Hideto Fujita

14

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Hiroyuki Takamura

15

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Itasu Ninomiya

16

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Sachio Fushida

17

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Takashi Tani

18

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Takashi Fujimura

19

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Seiko Kitamura

20

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Hiroko Ikeda

21

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Koichi Tsuneyama

22

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

26 March 2012

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Oncology Letters

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

3

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

6

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

1186-1190

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Pancreatic stellate cells promote epithelial-mesenchymal transition in pancreatic cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3392576

2 October 2017

Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3392576

2 October 2017

Pancreatic Cancer Cells Resistant to Chemoradiotherapy Rich in “Stem-Cell-Like” Tumor Cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3392576

2 October 2017

Considerations for the use of plasma cytokeratin 18 as a biomarker in pancreatic cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3392576

2 October 2017

CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3392576

2 October 2017

Preoperative radiochemotherapy is successful also in patients with locally advanced rectal cancer who have intrinsically high apoptotic tumours.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3392576

2 October 2017

Role of myofibroblasts in innate chemoresistance of pancreatic carcinoma--epigenetic downregulation of caspases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3392576

2 October 2017

Cancer statistics, 2008

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3392576

2 October 2017

Irradiation-induced epithelial-mesenchymal transition (EMT) related to invasive potential in endometrial carcinoma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3392576

2 October 2017

Expression of snail in pancreatic cancer promotes metastasis and chemoresistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3392576

2 October 2017

Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3392576

2 October 2017

Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3392576

2 October 2017

Complex networks orchestrate epithelial-mesenchymal transitions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3392576

2 October 2017

Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3392576

2 October 2017

Epithelial-mesenchymal transitions in tumour progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3392576

2 October 2017

Estimating the world cancer burden: Globocan 2000.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3392576

2 October 2017

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3392576

2 October 2017

Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3392576

2 October 2017

Transformations between epithelium and mesenchyme: normal, pathological, and experimentally induced

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3392576

2 October 2017

Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3392576

23 September 2018

Preoperative chemoradiation in adenocarcinoma of the pancreas. A single centre experience advocating a new treatment strategy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3392576

23 September 2018

Development and characterization of gemcitabine-resistant pancreatic tumor cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3392576

23 September 2018

Pancreatic Cancer Registry in Japan: 20 years of experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/22783415

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An evaluation of radical resection for pancreatic cancer based on the mode of recurrence as determined by autopsy and diagnostic imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/22783415

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas

1 reference

https://pubmed.ncbi.nlm.nih.gov/22783415

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3892/OL.2012.657

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36084344&oldid=1867109321"